Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/19/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 744 publications

Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia.

Condition: Acute Myeloid Leukemia (AML)
Journal: Hematology/oncology and stem cell therapy
Treatment Used: Chimeric Antigen Receptor (CAR) T-Cell Therapy
Number of Patients: 0
Published: December 20, 2022

SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia.

Condition: Acute Myeloid Leukemia (AML)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Maintenance Therapy
Number of Patients: 0
Published: December 01, 2022

An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial).

Condition: Acute Promyelocytic Leukemia (APL)
Journal: Blood cancer journal
Treatment Used: All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) vs. All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) Plus Chemotherapy (CHT)
Number of Patients: 128
Published: November 20, 2022

Impact of posttransplant cyclophosphamide on the outcome of patients undergoing unrelated single-unit umbilical cord blood transplantation for pediatric acute leukemia.

Condition: Pediatric Acute Leukemia
Journal: BMC cancer
Treatment Used: Posttransplant Cyclophosphamide (PTCY)
Number of Patients: 52
Published: November 19, 2022

Current status and future perspective of CAR T-cell therapy for acute myeloid leukemia.

Condition: Acute Myeloid Leukemia (AML)
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Treatment Used: CAR T-Cell Therapy
Number of Patients: 0
Published: November 09, 2022

Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews.

Condition: Acute Myeloid Leukemia (AML)
Journal: International journal of clinical practice
Treatment Used: Hematopoietic Stem Cell Transplantation (HSCT)
Number of Patients: 0
Published: October 24, 2022

Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia.

Condition: High-Risk Acute Promyelocytic Leukemia (APL)
Journal: Journal of hematology & oncology
Treatment Used: Oral Arsenic and Retinoic Acid
Number of Patients: 54
Published: October 18, 2022

Updated treatment strategies for myelodysplastic syndromes.

Condition: Myelodysplastic Syndromes (MDS)
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Treatment Used: Hematopoietic Cell Transplantation, Erythropoiesis-Stimulating Agents, and Oral Iron Chelators
Number of Patients: 0
Published: October 02, 2022

Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Acute Promyelocytic Leukemia.

Condition: Relapsed Acute Promyelocytic Leukemia (APL)
Journal: Transplantation and cellular therapy
Treatment Used: Allogeneic Hematopoietic Cell Transplantation (HCT)
Number of Patients: 195
Published: September 30, 2022

AML-389 Phase 1/2 Study of SEL24/MEN1703, a First-in-Class Dual PIM/FLT3 Kinase Inhibitor, in Patients With IDH1/2-Mutated Acute Myeloid Leukemia: The DIAMOND-01 Trial.

Condition: IDH1/2-Mutated Acute Myeloid Leukemia (AML)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: SEL24/MEN1703, Dual PIM/FLT3 Kinase Inhibitor
Number of Patients: 20
Published: September 27, 2022

AML-484 First Results of a Phase II Study (STIMULUS-AML1) Investigating Sabatolimab + Azacitidine + Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia (ND AML).

Condition: Newly Diagnosed Acute Myeloid Leukemia (AML)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Sabatolimab Plus Azacitadine Plus Ventoclax
Number of Patients: 18
Published: September 27, 2022

AML-262 Pivekimab Sunirine (PVEK, IMGN632) Triplet With Azacitidine and Venetoclax Shows Broad Activity in Adverse Genetic Subsets of Relapsed/Refractory Acute Myeloid Leukemia and Reduced Infusion-Related Reactions.

Condition: Relapsed/Refractory Acute Myeloid Leukemia (AML)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Pivekimab Sunirine (PVEK) Triplet with Azacitidine and Venetoclax
Number of Patients: 29
Published: September 27, 2022
Showing 1-12 of 744

Last Updated: 02/19/2023